Myogen to Present at the Citigroup Small & Mid-Cap Conference
February 28 2006 - 4:00PM
Business Wire
Myogen, Inc. (Nasdaq:MYOG), a biopharmaceutical company focused on
the discovery, development and commercialization of small molecule
therapeutics for the treatment of cardiovascular disorders, today
announced that J. William Freytag, President and CEO, will present
a corporate overview at the Citigroup Small & Mid-Cap
Conference to be held March 14-16, 2006, in Las Vegas, Nevada. The
presentation will take place at 1:05 p.m. (PST) on Wednesday, March
15, 2006. There will be a live webcast of the presentation, which
will be accessible through a link posted on the investor relations
section of the Myogen website at http://investor.myogen.com/. The
webcast will be available for replay on Myogen's website through
March 31, 2006. Myogen has two product candidates in late-stage
clinical development: ambrisentan for the treatment of patients
with pulmonary arterial hypertension (PAH) and darusentan for the
treatment of patients with resistant hypertension. The company, in
collaboration with Novartis, also conducts a target and drug
discovery research program focused on the development of
disease-modifying drugs for the treatment of chronic heart failure
and related cardiovascular disorders. Please visit the company's
website at www.myogen.com. Safe Harbor Statement The anticipated
presentation will contain forward-looking statements that involve
significant risks and uncertainties, including those to be
discussed in the presentation and others that can be found in the
"Risk Factors" section of Myogen's Form 10-K for the year ended
December 31, 2004, and Myogen's periodic reports on Form 10-Q and
Form 8-K. Myogen does not undertake any obligation to update any
forward-looking statements contained in the anticipated
presentation as a result of new information, future events or
otherwise. The company cautions investors not to place undue
reliance on the forward-looking statements contained in this press
release or the presentation. No forward-looking statement can be
guaranteed and actual events and results may differ materially from
those projected.
Myogen (NASDAQ:MYOG)
Historical Stock Chart
From Apr 2024 to May 2024
Myogen (NASDAQ:MYOG)
Historical Stock Chart
From May 2023 to May 2024